Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c16d2144a81bfa32a665dca1e93c3d37 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd26b01290add74fcd334cfa1af25e00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9442a6e59f5e6f4ad55bf4be4c4415fd |
publicationDate |
2014-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20140118271-A |
titleOfInvention |
Composition for combination therapy containing anti-her2 antibody and anti-c-Met antibody |
abstract |
The present invention relates to a combination chemotherapeutic composition comprising anti-c-Met antibody and anti-her2 antibody as an effective ingredient, and a pharmaceutical composition for inhibiting angiogenesis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10189875-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101644982-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170047559-A |
priorityDate |
2013-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |